• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 407

Polysaccharide complex of konjac glucomannan (konjac), sodium alginate, and xanthan gum (polysaccharide complex KAX)

Intended Use: Use at levels up to seven percent as an ingredient to provide dietary fiber or to provide thickening or a stabilizing effect in yogurts, milk shakes and fruit smoothie-type drinks, frozen yogurt, ice cream bars, puddings, white and whole wheat breads, cookies, breakfast bars, granola-type bars, noodles, whole wheat cereals, meatless lasagna and macaroni/cheese, fruit juices, fruit juice bars, cereal beverages, and medical foods
Basis: Scientific procedures
Notifier: Inovo Biologic, Inc.
Notifier Address: 104-1240 Kensington Road NW, Suite 409
Calgary, Alberta
Date of filing: Oct 14, 2011
GRAS Notice (releasable information): GRN 407 (in PDF)
Date of closure: Apr 10, 2012
FDA's Letter: FDA has no questions